Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
14.99
+0.98 (7.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cadrenal Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -7.61 | -8.36 | -7.32 |
| Depreciation & Amortization | 0 | 0 | 0 |
| Other Amortization | - | 0.01 | 0.07 |
| Stock-Based Compensation | 0.76 | 0.71 | 1.01 |
| Other Operating Activities | -0 | 3.96 | 4.26 |
| Change in Accounts Payable | 0.36 | -0.24 | 0.44 |
| Change in Other Net Operating Assets | 0.23 | 0.38 | 0.22 |
| Operating Cash Flow | -6.26 | -3.53 | -1.31 |
| Capital Expenditures | - | -0 | -0 |
| Investing Cash Flow | - | -0 | -0 |
| Total Debt Issued | - | - | 1.34 |
| Short-Term Debt Repaid | - | -0.25 | - |
| Total Debt Repaid | - | -0.25 | - |
| Net Debt Issued (Repaid) | - | -0.25 | 1.34 |
| Issuance of Common Stock | 1.52 | 12.15 | 0.01 |
| Financing Cash Flow | 1.52 | 11.9 | 1.35 |
| Net Cash Flow | -4.75 | 8.37 | 0.04 |
| Free Cash Flow | -6.26 | -3.53 | -1.32 |
| Free Cash Flow Per Share | -5.81 | -3.93 | -2.50 |
| Levered Free Cash Flow | -3.62 | -3.92 | - |
| Unlevered Free Cash Flow | -3.62 | -3.92 | - |
| Change in Net Working Capital | -0.59 | -0.14 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.